Accessibility Menu
 

Quantumzyme

(OTC) QTZM

Current PriceN/A
Market CapN/A
Since IPO (2024)-87%
5 YearN/A
1 Year-35%
1 Month-19%

Quantumzyme Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$4.48

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

QTZM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quantumzyme

Industry

Biotechnology

Employees

1

CEO

Naveen Krishna Rao Kulkarni

Headquarters

San Diego, CA 92127, US

QTZM Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

10%

Return on Capital

24%

Return on Assets

-75344%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$180.54K

EBITDA

$178.04K

Operating Cash Flow

$125.18K

Capital Expenditure

$0.00

Free Cash Flow

$125.18K

Cash & ST Invst.

$584.00

Total Debt

$249.08K

Quantumzyme Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

1

N/A

Net Income

$4.33M

N/A

EBITDA

$1.38K

N/A

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$232.01K

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$232.07K

N/A

Return on Assets

-75343.86%

N/A

Return on Invested Capital

24.15%

N/A

Free Cash Flow

$23.90K

N/A

Operating Cash Flow

$23.90K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TSETrinseo PLC
$0.13-37.50%
NTICNorthern Technologies International Corporation
$8.00+0.50%
LOOPLoop Industries, Inc.
$1.35+0.37%
ALTOAlto Ingredients, Inc.
$5.52+3.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$94.48-0.00%
NOKNokia
$12.91+0.04%
SOFISoFi Technologies
$16.10+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%

Questions About QTZM

What is the current price of Quantumzyme?

Quantumzyme is trading at N/A per share.

What is the 52-week range for Quantumzyme?

Over the past 52 weeks, Quantumzyme has traded between N/A and N/A.

How much debt does Quantumzyme have?

As of the most recent reporting period, Quantumzyme reported total debt of $232,066.

How much cash does Quantumzyme have on hand?

Quantumzyme reported $59 in cash and cash equivalents in its most recent financial results.

What is Quantumzyme’s dividend yield?

Quantumzyme does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.